Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Babchia N et al. – Activated PI3K/Akt attenuates the inhibitory effects of rapamycin on cell proliferation and thus serves as a negative feedback mechanism. This finding suggests that rapamycin is unlikely to inhibit uveal melanoma growth. In contrast, targeting PI3K while inhibiting B–Raf/ERK may be a promising approach to reduce proliferation of uveal melanoma cells.

Related Articles

A reappraisal of the significance of largest basal diameter of posterior uveal melanoma
Eye, 11/02/09    Relevance Score: 68%

Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease
Current Opinion in Ophthalmology, 10/27/09    Relevance Score: 67%

Surgical management of liver metastases from uveal melanoma: 16 years experience at the Institut Curie
European Journal of Surgical Oncology, 10/21/09    Relevance Score: 67%

Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey
Investigative Ophthalmology and Visual Science, 10/15/09    Relevance Score: 67%

Molecular Prognostic Testing and Individualized Patient Care in Uveal Melanoma
American Journal of Ophthalmology, 10/06/09    Relevance Score: 67%

Today in Oncology...keeping you current

Melanoma-Associated Retinopathy
Archives of Ophthalmology, 12/18/09

Management and outcome of unilateral retinoblastoma
Journal of American Association for Pediatric Ophthalmology and Strabismus , 12/17/09

Oxidative Stress in Retinoblastoma: Correlations with Clinicopathologic Features and Tumor Invasiveness
Current Eye Research, 12/17/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address